These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma. Awedan AA Ann Transplant; 2002; 7(2):38-43. PubMed ID: 12416471 [TBL] [Abstract][Full Text] [Related]
3. Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation. Slavin S; Morecki S; Weiss L; Or R J Hematother Stem Cell Res; 2002 Apr; 11(2):265-76. PubMed ID: 11983098 [TBL] [Abstract][Full Text] [Related]
4. Stem cell transplantation for severe autoimmune diseases: progress and problems. Marmont AM Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258 [TBL] [Abstract][Full Text] [Related]
6. Epithelial and mesenchymal stem cells from the umbilical cord lining membrane. Lim IJ; Phan TT Cell Transplant; 2014; 23(4-5):497-503. PubMed ID: 24636188 [TBL] [Abstract][Full Text] [Related]
7. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [TBL] [Abstract][Full Text] [Related]
8. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Resnick IB; Shapira MY; Slavin S Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565 [TBL] [Abstract][Full Text] [Related]
9. A new concept of stem cell disorders and their new therapy. Ikehara S J Hematother Stem Cell Res; 2003 Dec; 12(6):643-53. PubMed ID: 14977474 [TBL] [Abstract][Full Text] [Related]
10. Intra-bone marrow-bone marrow transplantation: a new strategy for treatment of stem cell disorders. Ikehara S Ann N Y Acad Sci; 2005 Jun; 1051():626-34. PubMed ID: 16127003 [TBL] [Abstract][Full Text] [Related]
11. Physician Education: Myelodysplastic Syndrome. Yoshida Y Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004 [TBL] [Abstract][Full Text] [Related]
12. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders. Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R Clin Transpl; 2003; ():275-82. PubMed ID: 15387119 [TBL] [Abstract][Full Text] [Related]
18. Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Marmont AM Best Pract Res Clin Haematol; 2004 Jun; 17(2):223-32. PubMed ID: 15302336 [TBL] [Abstract][Full Text] [Related]
19. Cell therapy for heart failure--muscle, bone marrow, blood, and cardiac-derived stem cells. Ott HC; Davis BH; Taylor DA Semin Thorac Cardiovasc Surg; 2005; 17(4):348-60. PubMed ID: 16428043 [TBL] [Abstract][Full Text] [Related]
20. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation. Statkute L; Verda L; Oyama Y; Traynor A; Villa M; Shook T; Clifton R; Jovanovic B; Satkus J; Loh Y; Quigley K; Yaung K; Gonda E; Krosnjar N; Spahovic D; Burt RK Bone Marrow Transplant; 2007 Mar; 39(6):317-29. PubMed ID: 17277794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]